admin

Ann-Marie Slavin and Siobhan Donaghy

Modern Democracy ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in

Portfolio company, Modern Democracy, ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in.Congratulations to Siobhan Donaghy and her team on delivering this great result for the recent GB elections. The below article is taken from: https://syncni.com/article/11966/derry-based-company-ensures-smooth-gb-elections-for-4-5m-voters-as-record-number-of-councils-adopt-digital-check-in Derry-based company Modern Democracy is forecasting further growth ahead of the […]

Modern Democracy ensures smooth running of GB elections for 4.5m voters as record number of Councils adopt digital check-in Read More »

Neurovalens closes £2.1m funding round

Neurovalens, a Belfast-headquartered specialist in non-invasive neuro-technology, has closed a £2.1m funding round with existing investors in preparation for a $40m-$50m Series B fundraising round. The firm has also received clearance from the US Food & Drug Administration (FDA) for its Modius Stress device. The below article is taken from: https://www.insidermedia.com/news/ireland/neurovalens-closes-2.1m-funding-round?utm_source=ireland_newsletter&utm_campaign=ireland_news_tracker&utm_medium=deals_article The company, whose medical

Neurovalens closes £2.1m funding round Read More »

Clarendon is hiring

Clarendon Fund Managers is a leading Belfast based venture capital firm dedicated to investing in innovative businesses with high growth potential across the whole of Northern Ireland. We specialise in supporting high growth companies across various industries, from software to healthcare, with a focus on driving impactful change and generating significant returns for our investors.

Clarendon is hiring Read More »

IFNI-logo

Investment Fund for Northern Ireland Roadshows hailed a great success

Source: Press Release – March 13, 2024 – British Business Bank (british-business-bank.co.uk) £70million Investment Fund for Northern Ireland (IFNI) will be split between debt and equity support for smaller businesses IFNI will tackle an identified funding gap throughout Northern Ireland Roadshow events reveal access to finance appetite among smaller businesses Several IFNI deals already in

Investment Fund for Northern Ireland Roadshows hailed a great success Read More »

The Boatyard Distillery Awarded No.6 in Drinks International’s Bartenders’ Choice

Congratulations to portfolio company, The Boatyard Distillery and, in particular, Joe McGirr and Declan McGurk, on this significant recognition. The Drinks International Report is seen as the global authority for the spirits world with the top 100 bars globally contributing to its publication. Boatyard climbed the rankings of both the top trending Vodka and Gin lists, and also made

The Boatyard Distillery Awarded No.6 in Drinks International’s Bartenders’ Choice Read More »

Investment Fund for Northern Ireland Roadshows – February 2024

Calling all SMEs, business advisors, accountants, bankers and lawyers supporting smaller businesses. Join us and the British Business Bank at the below roadshows to find out more about how the Investment Fund for Northern Ireland could help support the local economy: 📍 Newry, 6 February: https://lnkd.in/dWxJ3Y5g 📍 Omagh, 7 February: https://bit.ly/3NTS6ag 📍 Derry Londonderry, 7 February: bit.ly/3vyw5Y2 📍

Investment Fund for Northern Ireland Roadshows – February 2024 Read More »

CV6 Receive MHRA Approval for UK-Wide Trials

Congratulations to portfolio company, CV6 Therapeutics, (NI) Ltd. and, in particular, Robert D. Ladner, Ph.D. on this significant commercial milestone. We look forward to following developments with interest as the company commences its first-in-human clinical trial. Article taken from: CV6 Therapeutics Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial (yahoo.com) CV6 Therapeutics

CV6 Receive MHRA Approval for UK-Wide Trials Read More »

Neurovalens Receive FDA Clearance for its Modius Sleep Device

Congratulations to portfolio company, Neurovalens, and its CEO, Jason McKeown, on receiving clearance from the FDA on its Modius Sleep device for the treatment of chronic insomnia! A big milestone for the company – well done to the whole Neurovalens team! Article taken from: https://www.massdevice.com/fda-clears-insomnia-treating-device-neurovalens/ Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic

Neurovalens Receive FDA Clearance for its Modius Sleep Device Read More »

ANGOKA TO REVEAL NEXT GENERATION SECURITY TO PROTECT “LAST MILE” COMMUNICATIONS

Belfast-based cyber security leader ANGOKA is to unveil a new solution which offers robust security in the face of emerging quantum threats about to confront our daily lives. Article taken from: https://angoka.io/angoka-to-reveal-next-generation-security-to-protect-last-mile-communications/ The new technology provides quantum-secure last mile key exchange (the security of data fundamentally relies on a secure exchange of cryptographic keys between

ANGOKA TO REVEAL NEXT GENERATION SECURITY TO PROTECT “LAST MILE” COMMUNICATIONS Read More »